ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

Funding opportunities listed.

February 20, 2004

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010